Loading...
Vaccine
India Pharmaceutical Trade Intelligence
Who Supplies Vaccine to India from GERMANY
India's vaccine imports from GERMANY total $138.0B across 57 shipments from 9 foreign suppliers. GLAXOSMITHKLINE BIOLOGICALS SA leads with $138.0B in import value; the top 5 suppliers together control 100.0% of this origin. Leading Indian buyers include GLAXOSMITHKLINE PHARMACEUTICALS LIMITED. This corridor reflects India's pharmaceutical import demand for vaccine — a diversified sourcing base with multiple active suppliers from GERMANY.
Top foreign suppliers (GERMANY) — Ranked by import value
GLAXOSMITHKLINE BIOLOGICALS SA is the leading Vaccine supplier from GERMANY to India, with import value of $138.0B across 29 shipments. The top 5 suppliers — GLAXOSMITHKLINE BIOLOGICALS SA, BOEHRINGER INGELHEIM VETMEDICA GMBH, AZENTA GERMANY GMBH, ELANCO ANIMAL HEALTH INC, ADIRAMEDICA LLC — collectively account for 100.0% of total import value from this origin.
Top foreign suppliers (GERMANY)
Ranked by import value (USD) · Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | GLAXOSMITHKLINE BIOLOGICALS SA | $138.0B | 29 | 100.0% |
| 2 | BOEHRINGER INGELHEIM VETMEDICA GMBH | $1.5M | 17 | 0.0% |
| 3 | AZENTA GERMANY GMBH | $77.2K | 1 | 0.0% |
| 4 | ELANCO ANIMAL HEALTH INC | $48.8K | 2 | 0.0% |
| 5 | ADIRAMEDICA LLC | $9.2K | 1 | 0.0% |
| 6 | FISHER CLINICAL SERVICES | $5.5K | 2 | 0.0% |
| 7 | FISHER CLINICAL SERVICES... | $5.0K | 1 | 0.0% |
| 8 | INTERNATIONABLE LUDWIGS-ARZNEIMITTEL GMBH & CO. KG | $405 | 3 | 0.0% |
| 9 | M/S. LMU MUNICH | $285 | 1 | 0.0% |
Showing top 9 of 9 foreign suppliers · Indian Customs (DGFT) · TransData Nexus
Top Indian buyers (importing from GERMANY)
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | GLAXOSMITHKLINE PHARMACEUTICALS LIMITED | $138.0B | 28 | 100.0% |
| 2 | BOEHRINGER INGELHEIM INDIA PRIVATE LIMITED | $1.5M | 17 | 0.0% |
| 3 | CHIRON BEHRING VACCINES PRIVATE LIMITED | $427.0K | 1 | 0.0% |
| 4 | TAKEDA BIOPHARMACEUTICALS INDIA PRIVATE LIMITED | $77.2K | 1 | 0.0% |
| 5 | ELANCO INDIA PRIVATE LIMITED | $48.8K | 2 | 0.0% |
| 6 | BHARAT SERUMS AND VACCINES LIMITED | $9.2K | 1 | 0.0% |
| 7 | IQVIA RDS INDIA PRIVATE LIMITED | $5.5K | 2 | 0.0% |
| 8 | IQVIA RDS (INDIA) PRIVATE LIMITED | $5.0K | 1 | 0.0% |
| 9 | ZYDUS LIFESCIENCES LIMITED | $405 | 3 | 0.0% |
| 10 | MYNVAX PRIVATE LIMITED | $285 | 1 | 0.0% |
Import Statistics
- Import Value
- $138.0B
- Shipments
- 57
- Foreign Suppliers
- 9
- Indian Buyers
- 10
- Avg. Shipment
- $2.4B
Other Vaccine Import Origins
Frequently Asked Questions — Vaccine Imports from GERMANY
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
QWho are the top Vaccine suppliers from GERMANY to India?
The top Vaccine suppliers from GERMANY to India include GLAXOSMITHKLINE BIOLOGICALS SA, BOEHRINGER INGELHEIM VETMEDICA GMBH, AZENTA GERMANY GMBH. The leading supplier is GLAXOSMITHKLINE BIOLOGICALS SA with import value of $138.0B USD across 29 shipments. India imported Vaccine worth $138.0B USD from GERMANY in total across 57 shipments.
QHow much Vaccine does India import from GERMANY?
India imported Vaccine worth $138.0B USD from GERMANY across 57 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
QWho are the main Indian buyers of Vaccine from GERMANY?
The main Indian buyers of Vaccine sourced from GERMANY include GLAXOSMITHKLINE PHARMACEUTICALS LIMITED, BOEHRINGER INGELHEIM INDIA PRIVATE LIMITED, CHIRON BEHRING VACCINES PRIVATE LIMITED. The largest buyer is GLAXOSMITHKLINE PHARMACEUTICALS LIMITED with $138.0B in imports across 28 shipments.
QWhat is the total value of Vaccine imports from GERMANY to India?
The total value of Vaccine imports from GERMANY to India is $138.0B USD, across 57 shipments and 9 foreign suppliers. Data source: Indian Customs (DGFT).
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
SS
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: GERMANY to India pharmaceutical import trade corridor identified from Indian Customs (DGFT) shipping bill records for Vaccine.
- 2.Supplier/Buyer Matching: 9 foreign suppliers from GERMANY and 10 Indian buyers identified using company name normalization across customs records.
- 3.Value Aggregation: Total import value of $138.0B aggregated from 57 verified shipping bill records. All values reported in FOB USD as recorded by Indian Customs.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
57 Verified Shipments
9 suppliers, 10 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists